We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study Finds Allergies Rampant in U.S.

By HospiMedica staff writers
Posted on 19 Aug 2005
According to a large national study, more than 50% of the U.S. More...
population tested positive to one or more allergens. The findings were reported in the August 2005 issue of the Journal of Allergy and Clinical Immunology.

Data from the study showed that 54.3% of people aged six to 59 had a positive skin test response to at least one of the 10 allergens tested. The highest prevalence rates were for dust mite, rye, ragweed, and cockroach, with about 25% of the population testing positive to each allergen. Peanut allergy was the least common, with only 9% of the population reacting positively.

Many people are vulnerable to asthma, hay fever, and eczema. "Asthma is one of the world's most significant chronic health conditions,” noted David A. Schwartz, M.D., director of the U.S. National Institute of Environmental Health Sciences (NIEHS, Bethesda, MD, USA), one of the study partners. "Understanding what may account for the rising worldwide asthma rate will allow us to develop more-effective prevention and treatment approaches.”

The study, called the third National Health and Nutrition Examination Survey (NHANES III), is a nationally representative survey conducted by the U.S. Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) between 1988 and 1994 to determine the health and nutritional status of the population. Around 10,500 subjects participated in the skin testing. A positive test was determined by the size of the reaction on the skin. The 10 allergens tested were: dust mite, German cockroach, cat, perennial rye, short ragweek, Bermuda grass, Russian thistle, white oak, "alternia alternate,” and peanuts.
"Much more research is needed in order for us to understand the complex relationships between exposures to allergens, the development of allergic sensitization, and the onset and exacerbation of allergic diseases such as asthma,” said Dr. Darryl C. Zeldin, M.D., senior author of the study.




Related Links:
National Institute of Environmental Health Sciences

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.